Investors seeking floating-rate income have increasingly turned to CLO ETFs, which package pools of senior secured corporate loans into tradable tranches. CLOI and CLOZ sit within the same structured-credit niche but occupy very different points on the risk spectrum. This ETF comparison matters now because elevated interest rates have kept floating-rate instruments in demand, while a resilient corporate credit cycle has compressed spreads. The two funds do not compete on identical exposure; rather, they offer alternative ways to express a view on the same underlying loan market, with CLOI favoring safety and CLOZ favoring income. I also checked this using Tickeron’s AI Screener to see how the funds compare to others in the industry.
The VanEck CLO ETF (CLOI) is an actively managed fund sub-advised by PineBridge Investments. It seeks capital preservation and current income by investing at least 80% of its assets in investment-grade-rated tranches of collateralized loan obligations of any maturity. The portfolio typically holds more than 100 individual CLO tranches plus cash and short-term government instruments, reducing single-manager concentration. Representative positions have included Warwick Capital CLO 3, Rockford Tower CLO 2022-3, TCW CLO 2017-1A, Trinitas CLO XIV, and Bain Capital Credit CLO 2017-2, with no single holding dominating the book. The fund carries a net expense ratio of 0.36% and distributes income monthly, with a 30-day SEC yield near 5%. Because it focuses on senior, investment-grade tranches, CLOI prioritizes stability over yield maximization and is classified as non-diversified.
The Panagram BBB-B CLO ETF (CLOZ), managed by Panagram Structured Asset Management under the Eldridge brand, is an actively managed fund investing at least 80% of net assets in CLO tranches rated between BBB+ and B-. These mezzanine tranches sit below the senior, investment-grade layers in the payment waterfall, meaning they absorb losses earlier and therefore compensate investors with higher coupons. The fund holds roughly 150 to 190 positions, with exposure spread across managers such as Octagon, Madison Park Funding, CIFC, Oak Hill Advisors, and Bain Capital Credit. Its credit profile has historically split between BBB-rated (about 48%) and BB-rated (about 43%) tranches. CLOZ charges a 0.50% expense ratio and has delivered a 30-day SEC yield near 9%, reflecting its deliberately lower credit quality and higher income orientation.
Both funds operate in the collateralized loan obligation market, a large segment of structured credit that securitizes floating-rate leveraged loans. The current environment has been broadly supportive: persistently elevated short-term interest rates keep floating-rate coupons attractive, while resilient corporate earnings and limited default activity have supported loan prices. Heavy refinancing and reset activity has allowed CLO managers to extend reinvestment periods and lock in tighter funding costs. At the same time, the sector faces tail risks tied to covenant-lite lending, concentration in private-equity-backed borrowers, and any deterioration in credit conditions. These dynamics lift both funds' income potential but have an outsized effect on lower-rated tranches, making CLOZ more sensitive to spread movements and default expectations than CLOI. From what I see, this backdrop reinforces the importance of matching the right fund to an investor’s risk tolerance.
In recent market cycles, CLOZ has generated meaningfully higher total returns and distributions than CLOI, consistent with its mezzanine exposure and roughly double the yield. However, this relative positioning comes with more pronounced drawdowns and price volatility during risk-off episodes, when lower-rated tranches reprice more sharply. CLOI, by contrast, has exhibited a smoother path and near-negligible beta to equities, trading more like a high-quality floating-rate bond portfolio. On a risk-adjusted basis, the funds' profiles diverge: CLOZ favors investors prioritizing current income, while CLOI suits those seeking stability and capital preservation. Sector momentum and credit conditions remain the dominant drivers of relative performance between the two. I’m watching this closely as credit conditions evolve.
When comparing ETFs like these, I often rely on Tickeron’s AI Screener to quickly filter for yield, volatility, and credit-quality metrics across the structured-credit space. It helps surface relevant data points without manual effort and supports a more disciplined approach to portfolio construction.
Weighing structural strength, cost efficiency, diversification, credit quality, and relative risk exposure, Tickeron's AI would likely favor CLOI over CLOZ. While CLOZ offers superior yield and higher raw returns in benign conditions, its mezzanine exposure introduces greater drawdown sensitivity and credit risk. CLOI combines a lower expense ratio, senior investment-grade holdings, deeper liquidity, and more consistent volatility characteristics, producing a more favorable risk-adjusted profile across recent market cycles. The verdict is probabilistic rather than prescriptive, reflecting the trade-off between income and stability that defines these two funds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
CLOI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 3 of 8 cases where CLOI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 38%.
The Moving Average Convergence Divergence (MACD) for CLOI just turned positive on November 06, 2026. Looking at past instances where CLOI's MACD turned positive, the stock continued to rise in 8 of 48 cases over the following month. The odds of a continued upward trend are 17%.
Following a +0.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLOI advanced for three days, in 96 of 438 cases, the price rose further within the following month. The odds of a continued upward trend are 22%.
The Aroon Indicator entered an Uptrend today. In 120 of 757 cases where CLOI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 16%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLOI as a result. In 6 of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 32%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLOI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 14%.